drugset / Trial / NCT01173471
A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate the efficacy of systemically administered AZD4017, compared with placebo, over a 28-day period in patients with raised intra-ocular pressure (IOP).
Timeline
- Start
- 2010-12
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD4017 | Small molecule | 200 mg | Oral |
| Subject | AZD4017 | Small molecule | 800 mg | Oral |